FDA's New Vape Enforcement Policy Raises Alarm Among Experts

In a move that has drawn sharp criticism from public health advocates, the U.S. Food and Drug Administration (FDA) recently announced a revised enforcement approach for flavored e-cigarettes and nicotine pouches. The policy effectively grants some manufacturers a temporary reprieve from penalties, even if they are selling products without formal authorization. This shift comes amid a massive backlog of applications from vaping companies seeking FDA approval. Below, we break down the key aspects of this controversial guidance in a question-and-answer format.

1. What exactly did the FDA announce regarding flavored vapes and nicotine pouches?

The FDA issued new guidance stating that it will not prioritize enforcement actions against certain manufacturers who are currently selling flavored e-cigarettes or nicotine pouches without FDA authorization. Under normal circumstances, selling such products before receiving marketing approval is illegal. However, the agency said it will focus its limited resources on other violations, effectively giving these companies a temporary pass. This decision applies to products that have pending applications with the FDA, provided the manufacturers meet specific conditions. The move is intended to manage the agency's overwhelming workload, but critics argue it rewards noncompliance and undermines public health goals.

2. Why is the FDA granting this leniency to some illegal sellers?

The FDA is currently drowning in a mountain of applications from e-cigarette and nicotine pouch makers seeking permission to sell their products. As of early 2024, thousands of applications remain unprocessed, creating a regulatory logjam. To ease the burden, the agency decided to deprioritize enforcement against companies that have already submitted applications and are selling their products while waiting for a decision. The logic is that pursuing every illegal sale would divert resources from processing the backlog. Yet public health experts warn this approach creates a perverse incentive: companies can flood the market with unauthorized flavors without immediate consequences, potentially increasing youth appeal.

3. What are the two conditions companies must meet to benefit from this policy?

According to the guidance, a manufacturer qualifies for enforcement discretion if it meets two key conditions. First, the company must have submitted a timely premarket tobacco product application (PMTA) to the FDA that is still under review. Second, the manufacturer must not have received a denial order or a refusal to file notice. In other words, simply having an application pending—even if it was filed years ago—allows the company to keep selling its flavored vapes or nicotine pouches legally, for now. The FDA emphasizes that this is not a blanket amnesty, but rather a prioritization strategy. Critics, however, say the policy is vague and could be exploited by bad actors.

4. How do experts view this new enforcement approach?

Public health experts and anti-smoking advocates have reacted with alarm. One expert described the guidance as a "get-out-of-jail-free card" for companies that have been flouting the law. They argue that allowing unauthorized flavored products to remain on shelves especially threatens young people, who are drawn to sweet and fruity flavors. The American Lung Association and other groups have called on the FDA to reverse course. Conversely, some industry representatives view the policy as a pragmatic step to reduce regulatory chaos, but the overwhelming sentiment among health professionals is that it weakens enforcement at a critical time when youth vaping rates, while declining, remain unacceptably high.

5. What does this mean for the FDA's backlog of vape applications?

The FDA has been under pressure from Congress and the courts to clear its backlog of PMTAs. By easing enforcement for pending applicants, the agency hopes to focus its staff on reviewing applications rather than policing unauthorized sales. However, this creates a paradox: the more applications that pile up, the longer companies can sell illegally. Some applicants have waited over three years for a decision. The new policy effectively rewards those who jumped the gun, while penalizing firms that waited for approval. Experts worry the backlog could persist indefinitely, leaving consumers exposed to unregulated flavored products that may have unknown health risks.

6. Are there any potential consequences for youth vaping rates?

Yes—and they could be severe. Flavored e-cigarettes and nicotine pouches have been linked to the surge in youth nicotine use over the past decade. Despite federal flavor restrictions enacted in 2020, many flavored products remain available through loopholes. The FDA's new policy could embolden manufacturers to reintroduce popular flavors like mango, cotton candy, and mint, which are especially enticing to teenagers. While the agency claims the guidance is temporary, experts fear it will be difficult to reverse once companies grow accustomed to leniency. Monitoring data from the National Youth Tobacco Survey will be crucial in determining whether this policy leads to an uptick in underage usage.

7. What should consumers and retailers know about this policy change?

Consumers should be aware that not all flavored vapes or nicotine pouches on store shelves are legally authorized. The FDA's new guidance means many products are being sold without a full safety and efficacy review. Retailers, too, face a tricky landscape: selling unauthorized flavored items could still invite future enforcement if the FDA changes course. The agency retains the right to take action at any time against any product it deems a public health threat. Therefore, both consumers and retailers should check the FDA's online database of authorized products and stay informed about potential updates. As experts note, this policy is unlikely to be the final word on the matter.